UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A ligand-reversible dimerization system for controlling protein–protein interactions

Proceedings of the National Academy of Sciences - PNAS, 2000-06, Vol.97 (13), p.7096-7101

2000

Volltextzugriff (PDF)

Structure-Based Design of an Osteoclast-Selective, Nonpeptide Src Homology 2 Inhibitor with in vivo Antiresorptive Activity

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (17), p.9373-9378

2000

Volltextzugriff (PDF)

Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine-based Compounds

Chemical biology & drug design, 2006-01, Vol.67 (1), p.46-57

2006

Volltextzugriff (PDF)

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

Bioorganic & medicinal chemistry letters, 2003-09, Vol.13 (18), p.3067-3070

2003

Volltextzugriff (PDF)

Targeting protein kinases for bone disease: discovery and development of Src inhibitors

Current pharmaceutical design, 2002-01, Vol.8 (23), p.2049-2075

2002

Volltextzugriff (PDF)

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Journal of medicinal chemistry, 1999-10, Vol.42 (20), p.4088-4098

1999

Volltextzugriff (PDF)

Investigating Protein−Ligand Interactions with a Mutant FKBP Possessing a Designed Specificity Pocket

Journal of medicinal chemistry, 2000-03, Vol.43 (6), p.1135-1142

2000

Volltextzugriff (PDF)

Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interaction

Bioorganic & medicinal chemistry letters, 1996-12, Vol.6 (24), p.2983-2988

1996

Volltextzugriff (PDF)

The characterization of two monoclonal antibodies which react with high molecular weight antigens of asexual Plasmodium falciparum

Molecular and biochemical parasitology, 1992-09, Vol.54 (2), p.231-246

1992

Volltextzugriff (PDF)

Bone-Targeted pyrido[2,3- d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents

Bioorganic & medicinal chemistry letters, 2003-09, Vol.13 (18), p.3071-3074

2003

Volltextzugriff (PDF)

Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes

Blood, 1992-10, Vol.80 (8), p.2097-2104

1992

Volltextzugriff (PDF)

Normal human erythrocytes express CD36, and adhesion molecule of monocytes, platelets, and endothelial cells

Blood, 1992-10, Vol.80 (8), p.2105-2114

1992

Volltextzugriff (PDF)

Simultaneous Assay of Src SH3 and SH2 Domain Binding Using Different Wavelength Fluorescence Polarization Probes

Analytical biochemistry, 1999-11, Vol.275 (1), p.62-73

1999

Volltextzugriff (PDF)

Research Article: Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine-based Compounds

Chemical biology & drug design, 2006-01, Vol.67 (1), p.46-57

2006

Volltextzugriff (PDF)

Corrigendum to “Bone-Targeted Src Kinase Inhibitors: Novel Pyrrolo- and Pyrazolopyrimidine Analogues”[Bioorg. Med. Chem. Lett. 13 (2003) 3063]

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4519

2003

Volltextzugriff (PDF)

An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1

The American journal of tropical medicine and hygiene, 1993-03, Vol.48 (3), p.332-347

1993

Volltextzugriff (PDF)

Bone-targeted 2,6,9-trisubstituted purines: Novel inhibitors of Src tyrosine kinase for the treatment of bone diseases: Recent advances in the design of kinase inhibitors as novel therapeutic agents

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (18), p.3067-3070

2003

Volltextzugriff (PDF)

Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: Potent inhibitors of Src tyrosine kinase as novel antiresorptive agents: Recent advances in the design of kinase inhibitors as novel therapeutic agents

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (18), p.3071-3074

2003

Volltextzugriff (PDF)

A Ligand-Reversible Dimerization System for Controlling Protein Interactions

Proceedings of the National Academy of Sciences - PNAS, 2000-06, Vol.97 (13), p.7096-7101

2000

Volltextzugriff (PDF)

Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from West African patients

Blood, 1991-07, Vol.78 (1), p.226-236

1991

Volltextzugriff (PDF)

Purification and in vitro selection of rosette-positive (R+) and rosette-negative (R-) phenotypes of knob-positive Plasmodium falciparum parasites

The American journal of tropical medicine and hygiene, 1992-04, Vol.46 (4), p.371-381

1992

Volltextzugriff (PDF)

Immunochemical Characterization and Differentiation of Two ∼300-KD Erythrocyte Membrane-Associated Proteins of Plasmodium Falciparum, PfEMP1 and PfEMP3

The American journal of tropical medicine and hygiene, 1993-11, Vol.49 (5), p.552-565

1993

Volltextzugriff (PDF)

Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence

The American journal of tropical medicine and hygiene, 1990-08, Vol.43 (2 Pt 2), p.15-29

1990

Volltextzugriff (PDF)

Science funding

Nature (London), 1989-02, Vol.337 (6209), p.684-684

VAN SCHRAVENDIJK, MARIE ROSE

1989

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

A ligand-reversible dimerization system for controlling protein–protein interactions

Structure-Based Design of an Osteoclast-Selective, Nonpeptide Src Homology 2 Inhibitor with in vivo Antiresorptive Activity

Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine-based Compounds

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

Targeting protein kinases for bone disease: discovery and development of Src inhibitors

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Investigating Protein−Ligand Interactions with a Mutant FKBP Possessing a Designed Specificity Pocket

Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interaction

SAR of Carbon-Linked, 2-Substituted Purines: Synthesis and Characterization of AP23451 as a novel Bone-Targeted Inhibitor of Src Tyrosine Kinase With In Vivo Anti-Resorptive Activity

The characterization of two monoclonal antibodies which react with high molecular weight antigens of asexual Plasmodium falciparum

Bone-Targeted pyrido[2,3- d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents

Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes

Normal human erythrocytes express CD36, and adhesion molecule of monocytes, platelets, and endothelial cells

Simultaneous Assay of Src SH3 and SH2 Domain Binding Using Different Wavelength Fluorescence Polarization Probes

Research Article: Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine-based Compounds

Corrigendum to “Bone-Targeted Src Kinase Inhibitors: Novel Pyrrolo- and Pyrazolopyrimidine Analogues”[Bioorg. Med. Chem. Lett. 13 (2003) 3063]

An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1

Bone-targeted 2,6,9-trisubstituted purines: Novel inhibitors of Src tyrosine kinase for the treatment of bone diseases: Recent advances in the design of kinase inhibitors as novel therapeutic agents

Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: Potent inhibitors of Src tyrosine kinase as novel antiresorptive agents: Recent advances in the design of kinase inhibitors as novel therapeutic agents

A Ligand-Reversible Dimerization System for Controlling Protein Interactions

Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from West African patients

Purification and in vitro selection of rosette-positive (R+) and rosette-negative (R-) phenotypes of knob-positive Plasmodium falciparum parasites

Immunochemical Characterization and Differentiation of Two ∼300-KD Erythrocyte Membrane-Associated Proteins of Plasmodium Falciparum, PfEMP1 and PfEMP3

Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence

Science funding

Suchergebnisse filtern